Concepedia

Natalie Ives

NI

Statistics

Publications

64

Citations

5.1K

H-Index

34

Active since

1999

Affiliations

University of Birmingham(Current)

Cancer Research UK Clinical Trials Unit

University College London

University Hospitals Birmingham NHS Foundation Trust

Loughborough University

Natalie Ives is an author at University of Birmingham specializing in medicine, pharmacotherapy, and parkinson disease.

Publications per year

1999–2025

64

Publications

64

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Michael Walsh, Peter A. Merkel, Chen Au Peh et al. · New England Journal of Medicine · 2020 · 861 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy

Gillian Dean, Simon Edwards, Natalie Ives et al. · AIDS · 2002 · 358 citations · Full text

Public Health, Infectious Diseases, Internal Medicine +15

Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease

Sunil Bhandari, Samir Mehta, Arif Khwaja et al. · New England Journal of Medicine · 2022 · 315 citations · Full text

Medicine, Nephrology, Pharmacotherapy +15

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

Michael Walsh, Peter A. Merkel, Chen Au Peh et al. · Trials · 2013 · 241 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Adjuvant Interferon in High-Risk Melanoma: The AIM HIGH Study—United Kingdom Coordinating Committee on Cancer Research Randomized Study of Adjuvant Low-Dose Extended-Duration Interferon Alfa-2a in High-Risk Resected Malignant Melanoma

B. W. Hancock, Keith Wheatley, SyedHasan Harris et al. · Journal of Clinical Oncology · 2003 · 228 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

1–5 of 64